BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11280214)

  • 41. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
    Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of hepatitis B and C markers in glomerular diseases.
    Enríquez R; Rodríguez JC; Sirvent AE; Amorós F; Ardoy F; Alvarez M; Royo G
    Scand J Urol Nephrol; 2007; 41(6):535-8. PubMed ID: 17853005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profile of glomerular diseases associated with hepatitis B and C: A single-center experience from India.
    Raveendran N; Beniwal P; D'Souza AV; Tanwar RS; Kimmatkar P; Agarwal D; Malhotra V
    Saudi J Kidney Dis Transpl; 2017; 28(2):355-361. PubMed ID: 28352020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Focal segmental glomerulosclerosis related to BK virus in a child with nephrotic syndrome. A case report].
    Velásquez-Jones L; Romero-Silva L; Ramón-García G; Portillo-Carrillo M; Valverde-Rosas S; Romero-Navarro B; Valencia-Mayoral P
    Rev Med Inst Mex Seguro Soc; 2009; 47(1):95-100. PubMed ID: 19624974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation.
    Taton B; Moreau K; Lepreux S; Bachelet T; Trimoulet P; De Ledinghen V; Pommereau A; Ronco P; Kamar N; Merville P; Couzi L
    Transpl Infect Dis; 2013 Dec; 15(6):E211-5. PubMed ID: 24103101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy.
    Coroneos E; Petrusevska G; Varghese F; Truong LD
    Am J Kidney Dis; 1996 Dec; 28(6):888-92. PubMed ID: 8957041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Focal and segmental glomerulosclerosis and porteinuria associated with unilateral renal agenesis.
    Kiprov DD; Colvin RB; McCluskey RT
    Lab Invest; 1982 Mar; 46(3):275-81. PubMed ID: 7062725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of the hepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy.
    Bhimma R; Coovadia HM; Adhikari M; Connolly CA
    Arch Pediatr Adolesc Med; 2003 Oct; 157(10):1025-30. PubMed ID: 14557165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Focal segmental glomerulosclerosis and hepatitis C virus: a case report.
    Motta M; Malaguarnera M; Restuccia N; Romano M; Vinci E; Pistone G
    Panminerva Med; 2001 Mar; 43(1):49-52. PubMed ID: 11319519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
    Bremer CT; Lastrapes A; Alper AB; Mudad R
    Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclosporine treatment of glomerular diseases.
    Klein M; Radhakrishnan J; Appel G
    Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C; Passerini P
    Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon alpha-2b treatment in an HIV-infected patient with hepatitis B virus induced nephrotic syndrome.
    Lidman C; Magnius L; Norder H; Weiland O
    Scand J Infect Dis; 1993; 25(1):133-5. PubMed ID: 8460337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hepatitis B virus, the main cause of membranous nephropathy in China].
    Chen G; Zhang Y; Zou W
    Zhonghua Yi Xue Za Zhi; 1995 Sep; 75(9):540-2, 574-5. PubMed ID: 8556545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of hepatitis B virus-associated nephropathy.
    Elewa U; Sandri AM; Kim WR; Fervenza FC
    Nephron Clin Pract; 2011; 119(1):c41-9; discussion c49. PubMed ID: 21677438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis-B-associated glomerulonephritis in children.
    Oner A; Tinaztepe K; Demircin G
    Turk J Pediatr; 1997; 39(2):239-46. PubMed ID: 9223922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy.
    Lai FM; Tam JS; Li PK; Lai KN
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(3):279-84. PubMed ID: 2494807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia.
    Lai KN; Tam JS; Lin HJ; Lai FM
    Nephron; 1990; 54(1):12-7. PubMed ID: 2296339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of anti-GBM glomerulonephritis superimposed on HBV-associated membranous nephropathy.
    Yamamoto T; Oseto S; Imakita N; Inada M; Fukunaga M
    CEN Case Rep; 2013 Nov; 2(2):239-247. PubMed ID: 28509304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.